Skip to content

Offering Psychedelic Treatments Before Assisted Dying for Psychiatric Conditions

Christopher Poppe, Jan Christoph Bublitz, Dimitris Repantis

JAMA Psychiatry August 1, 2025 DOI: 10.1001/jamapsychiatry.2025.1457

Summary

AI-generated from the abstract

The viewpoint argues that psychedelic treatment should be offered to individuals with psychiatric conditions as a form of life-preserving care prior to physician-assisted death, suggesting it may provide relief and reduce suffering, potentially altering the trajectory toward assisted death.

Study at a glance

Characteristics Viewpoint Peer reviewed
Population Persons with psychiatric conditions considering physician-assisted death
Key finding Psychedelic treatment may serve as life-preserving care for psychiatric patients before physician-assisted death.

Abstract

This Viewpoint describes the benefits of providing psychedelic treatment to persons with psychiatric conditions as life-preserving care before physician-assisted death.

Comments

No comments yet.

Log in to comment